Tisch MSRCNY will be closed for the holiday beginning on Monday, December 31st and will reopen on Wednesday, January 2nd at 9:00 AM. We wish you and your family a happy and healthy New Year!
This week, April 21st-27th, Dr. Sadiq, Dr. Williams, Dr. Bates and six members of the Tisch MSRCNY will be attending the 70th annual AAN conference in Los Angeles, California. They will be presenting four posters, as well as attending presentations given throughout the week. We are very excited...
Do you have any 2018 races or fundraising plans? Consider joining Team Tisch MS. Whether it is running, biking, swimming, being a proud supporter, or just wanting to promote an important cause, we need your support! Find out more!
Tisch MSRCNY will be closed on Monday, January 15th, in observance of Martin Luther King Jr. Day. "Faith is taking the first step even when you don't see the whole staircase." -Martin Luther King Jr.
This study, recently published in the journal JAMA Neurology, examined the use of Rituximab as a first-line MS treatment in Sweden. Rituximab is already extensively used in Sweden but this study showed the improved efficacy and safety of using Rituximab as a first MS treatment as compared to other...
For Immediate Release RESEARCHERS SHOW STEM CELL THERAPY MAY REVERSE DISABILITY IN MULTIPLE SCLEROSIS New York, NY – February 6, 2018 – Researchers at Tisch MS Research Center of New York (Tisch MSRCNY) have shown a stem cell-based treatment may reverse disability in progressive multiple sclerosis...
written by Dr. Armistead Williams A new report from an annual meeting of hematologists showed positive results for using hematopoietic stem cell transplantation (AHSCT) to treat relapsing-remitting MS. The results reflect what we already know about AHSCT: that it is highly effective in relapsing-...
Due to the impending storm and weather conditions, the Tisch MS Research Center of New York will be closed on Wednesday, March 21, 2018. Please stay safe and warm!